新冠肺炎后美国人类免疫缺陷病毒感染者病毒抑制轨迹的不稳定：一项中断时间序列分析。
Viral Suppression Trajectories Destabilized After Coronavirus Disease 2019 Among US People With Human Immunodeficiency Virus: An Interrupted Time Series Analysis.
机构信息
Division of HIV, ID, and Global Medicine, University of California, SanFrancisco, California, USA.
Division of Prevention Science, University of California, SanFrancisco, California, USA.
出版信息
Clin Infect Dis. 2024 Apr 10;78(4):991-994. doi: 10.1093/cid/ciad657.
Abstract
We examined changes in the proportion of people with human immunodeficiency virus (PWH) with virologic suppression (VS) in a multisite US cohort before and since the coronavirus disease 2019 (COVID-19) pandemic. Overall, prior gains in VS slowed during COVID-19, with disproportionate impacts on Black PWH and PWH who inject drugs.
摘要
我们考察了美国多地点队列中人类免疫缺陷病毒（HIV）感染者（PWH）病毒学抑制（VS）比例在 COVID-19 大流行前后的变化。总体而言，COVID-19 期间 VS 方面的前期进展有所放缓，对黑人 PWH 和注射吸毒者 PWH 的影响尤为显著。
相似文献
1
Viral Suppression Trajectories Destabilized After Coronavirus Disease 2019 Among US People With Human Immunodeficiency Virus: An Interrupted Time Series Analysis.
Clin Infect Dis. 2024 Apr 10;78(4):991-994. doi: 10.1093/cid/ciad657.
2
Impact of Multicomponent Support Strategies on Human Immunodeficiency Virus Virologic Suppression Rates During Coronavirus Disease 2019: An Interrupted Time Series Analysis.
Clin Infect Dis. 2022 Aug 24;75(1):e947-e954. doi: 10.1093/cid/ciac179.
3
Coronavirus Disease 2019 (COVID-19) Infection Among People With Human Immunodeficiency Virus in New York City: A Population-Level Analysis of Linked Surveillance Data.
Clin Infect Dis. 2021 Jun 15;72(12):e1021-e1029. doi: 10.1093/cid/ciaa1793.
4
Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States.
JAMA Netw Open. 2022 Jun 1;5(6):e2215934. doi: 10.1001/jamanetworkopen.2022.15934.
5
Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout.
Clin Infect Dis. 2023 May 24;76(10):1727-1734. doi: 10.1093/cid/ciad084.
6
Viral Load Suppression in People Living with HIV Before and During the COVID-19 Pandemic in Brooklyn, New York.
AIDS Behav. 2024 Sep;28(9):2961-2969. doi: 10.1007/s10461-024-04385-0. Epub 2024 Jun 5.
7
Spatial and temporal analysis of HIV clinical outcomes in Florida reveals counties with persistent racial and ethnic disparities during 2012-2019.
BMC Public Health. 2024 Mar 9;24(1):749. doi: 10.1186/s12889-024-17944-w.
8
Factors Associated With Severity of COVID-19 Disease in a Multicenter Cohort of People With HIV in the United States, March-December 2020.
J Acquir Immune Defic Syndr. 2022 Aug 1;90(4):369-376. doi: 10.1097/QAI.0000000000002989.
9
Variation in subsequent viral load testing and outcomes by visit type patterns in the first year of the COVID-19 pandemic at a large academic medical center in North Carolina.
Mhealth. 2025 Mar 21;11:18. doi: 10.21037/mhealth-24-69. eCollection 2025.
10
Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US.
JAMA Netw Open. 2022 Oct 3;5(10):e2236397. doi: 10.1001/jamanetworkopen.2022.36397.
引用本文的文献
1
Impact of the Coronavirus Disease 2019 Pandemic on Substance Use Disorder Risk Among People Living With Human Immunodeficiency Virus (HIV) Enrolled in HIV Care in the United States: An Interrupted Time Series Analysis.
Open Forum Infect Dis. 2024 Aug 26;11(9):ofae491. doi: 10.1093/ofid/ofae491. eCollection 2024 Sep.
2
Care challenges and silver linings in HIV and behavioral health service delivery for individuals living with HIV and severe mental illness during the COVID-19 pandemic: a qualitative study.
BMC Health Serv Res. 2024 May 31;24(1):690. doi: 10.1186/s12913-024-11146-1.
本文引用的文献
1
Demonstration Project of Long-Acting Antiretroviral Therapy in a Diverse Population of People With HIV.
Ann Intern Med. 2023 Jul;176(7):969-974. doi: 10.7326/M23-0788. Epub 2023 Jul 4.
2
Brief Report: The Influence of the COVID-19 Pandemic on the Physical, Social, and Mental Health of Black and Latinx Young People With HIV in the United States.
J Acquir Immune Defic Syndr. 2023 Jul 1;93(3):187-190. doi: 10.1097/QAI.0000000000003188.
3
The impact of the COVID-19 pandemic on mental health, associated factors and coping strategies in people living with HIV: a scoping review.
J Int AIDS Soc. 2023 Mar;26(3):e26060. doi: 10.1002/jia2.26060.
4
Impact of the COVID-19 Pandemic on HIV Healthcare Service Engagement, Treatment Adherence, and Viral Suppression in the United States: A Systematic Literature Review.
AIDS Behav. 2023 Jan;27(1):344-357. doi: 10.1007/s10461-022-03771-w. Epub 2022 Aug 2.
5
The potential effect of COVID-19-related disruptions on HIV incidence and HIV-related mortality among men who have sex with men in the USA: a modelling study.
Lancet HIV. 2021 Apr;8(4):e206-e215. doi: 10.1016/S2352-3018(21)00022-9. Epub 2021 Feb 19.
6
COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy Among Black Americans Living With HIV.
J Acquir Immune Defic Syndr. 2021 Feb 1;86(2):200-207. doi: 10.1097/QAI.0000000000002570.
7
Viral suppression rates in a safety-net HIV clinic in San Francisco destabilized during COVID-19.
AIDS. 2020 Dec 1;34(15):2328-2331. doi: 10.1097/QAD.0000000000002677.
8
Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models.
Lancet HIV. 2020 Sep;7(9):e629-e640. doi: 10.1016/S2352-3018(20)30211-3. Epub 2020 Aug 6.
9
Potential Influences of the COVID-19 Pandemic on Drug Use and HIV Care Among People Living with HIV and Substance Use Disorders: Experience from a Pilot mHealth Intervention.
AIDS Behav. 2021 Feb;25(2):354-359. doi: 10.1007/s10461-020-02976-1.
10
Regression based quasi-experimental approach when randomisation is not an option: interrupted time series analysis.
BMJ. 2015 Jun 9;350:h2750. doi: 10.1136/bmj.h2750.
Zotero 插件